{
  "docId": "019dd923-622c-750b-8b99-0c6502d9e87e",
  "docSlug": "0dd3bb0497df",
  "documentTitle": "American Battery Metals Corporation / Comstock Mining Inc. (ABML / LODE)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Ben Axler",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-03-10 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 26,
  "pageCount": 73,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Includes a screenshot of a class action lawsuit filing, a list of material weaknesses, and a stock price chart.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "callout_box",
    "screenshot",
    "line_chart"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-0c6502d9e87e/26",
  "deckHref": "/decks/019dd923-622c-750b-8b99-0c6502d9e87e",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-0c6502d9e87e.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-0c6502d9e87e#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.18,
        "w": 0.97,
        "x": 0.02,
        "y": 0.36
      },
      "kind": "callout",
      "text": "In March 2011, a class action lawsuit was filed against MacLellan and Radient claiming false statements were made related to a trial with the Mayo Clinic. During the course of 2009-2010, Radient engaged and issued shares as payment to 10 (ten!) firms for “investor relations” services, and in FY2010 expenses related to such activities totaled almost 15x revenue and accounted for one-third of SG&A in 2010. Rarely have we seen such extensive stock promotion expenses. Radient also disclosed 6 material weaknesses in its 2009 and 2010 10-Ks, and the Company’s inability to file financial statements for 3 years led the SEC to revoke its registration in 2014.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64055829-a5b6-4fe6-9edb-cae047781713",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "MacLellan’s company was sued for making false statements, found numerous material weaknesses, and eventually had its SEC registration revoked due to its inability to file financial statements for three years.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-e6ee-7118-8702-8beb99d02a28",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.23,
        "w": 0.25,
        "x": 0.74,
        "y": 0.75
      },
      "kind": "chart",
      "text": "RXTP 2009-2010 Stock Price Chart: Money Not Well Spent",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3536415d-146a-465c-bba8-9b6e16b3f72d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.42,
        "w": 0.23,
        "x": 0.02,
        "y": 0.56
      },
      "kind": "image",
      "text": "Shareholder Lawsuit Against MacLellan For False Claims",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a79a949c-7c3f-422c-9410-f734f5911b5e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.23,
        "x": 0.26,
        "y": 0.82
      },
      "kind": "list",
      "text": "LWPI, B&D Consulting, Strategic Growth International, Lyons Consulting, First International Capital Group, Boston Financial Partners, Catawaba LTD, Garden State Securities, JFS Investments, Uptick Marketing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "464f6370-5ca0-4287-a77b-878f7575ef60",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.82,
        "x": 0.17,
        "y": 0.26
      },
      "kind": "list",
      "text": "Radient Pharmaceuticals (OTC RXTP) was a specialty pharma company\nMacLellan held various Board positions and was Chairman and Chief Executive Officer from September 1992 to April 2014",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47512f13-6eeb-430c-8bd6-c58347c5c017",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.97,
        "x": 0.02,
        "y": 0.19
      },
      "kind": "paragraph",
      "text": "MacLellan's company was sued for making false statements, found numerous material weaknesses, and eventually had its SEC registration revoked due to its inability to file financial statements for three years.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8b180b0d-7ce6-4614-a120-eabe79f89c13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.47,
        "x": 0.26,
        "y": 0.56
      },
      "kind": "table",
      "text": "Material Weaknesses Disclosed in 2010 10-K",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97055a9b-601e-4b79-a5cb-4f9baa32e799",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.68,
        "x": 0.31,
        "y": 0.02
      },
      "kind": "title",
      "text": "Radient Pharmaceuticals (OTC:RXTP): We Believe An Example of False Claims, Ridiculous Stock Promotion Activity, And Failure",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "082674fd-dbfa-48ce-b18d-116ee9f1d87f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 40,
      "from": 21,
      "beatId": "e8902662-150b-4224-a3d2-0c3276dfe918",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Struggle",
      "beatSlug": "overcoming-monster-the-struggle",
      "evidence": "The deck highlights the struggles and challenges faced by ABML",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}